Executive record

Charles F. Wagner, Jr.

Most recent record: Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr. (named as the outgoing officer), effective January 1, 2027. See Vertex Pharmaceuticals Incorporated.

1 verified record

2026-09-01 · Transition

Vertex Pharmaceuticals Incorporated CFO transition: Jonathan Poole to succeed Charles F. Wagner, Jr.

This page lists only verified filing records that name Charles F. Wagner, Jr.; it is not a career history. Corrections: the corrections page.